O-2390
O-2390 is a synthetic cannabinoid that is used in scientific research. It is a selective CB2 receptor agonist, meaning it activates the CB2 receptor but not the CB1 receptor. This makes it useful for studying the effects of CB2 activation without the psychoactive effects associated with CB1 activation.
Chemistry[edit | edit source]
O-2390 is a member of the naphthoylindole family of synthetic cannabinoids. It is structurally similar to other synthetic cannabinoids such as JWH-018 and AM-2201, but differs in that it has a sulfonamide group. This gives it a unique pharmacological profile compared to other synthetic cannabinoids.
Pharmacology[edit | edit source]
As a CB2 receptor agonist, O-2390 has potential therapeutic applications in conditions where the CB2 receptor is involved. This includes inflammatory and autoimmune diseases, as well as pain and cancer. However, much more research is needed to fully understand the effects of O-2390 and its potential therapeutic uses.
Legal Status[edit | edit source]
The legal status of O-2390 varies by country. In some countries, it is classified as a controlled substance, while in others it is legal for research purposes. It is important to check the legal status of O-2390 in your country before purchasing or using it.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
